Stille AB

STIL · Nasdaq Stockholm · Healthcare

249.50SEK −0.2%last day

Price as of 2 October 2026

The price over the past year, with dividends: +24.8%

Performance

1 month

+10.9%

1 year

+24.8%

3 years, per year

+30.8%

5 years, per year

+13.8%

Largest fall, 3 years

−46.1%

Below the peak now

−9.6%

Volatility, 1 year

44.0%

Return with dividends reinvested.

Key figures

P/E

29.8

P/B

2.8

Dividend yield

0.0%

Return on equity

+9.4%

Net margin

+10.7%

Market value

223 m USD

Quality, value and trend

Where Stille stands against every Nordic stock today. 100 is best.

Quality96

Profitability and a sound balance sheet over time. Better than 96% of Nordic stocks.

Value33

The price measured against earnings, assets and cash flow. Better than 33% of Nordic stocks.

Trend62

The price development over the past year. Better than 62% of Nordic stocks.

Combined75

Quality, value and trend together. Better than 75% of Nordic stocks.

About Stille

Stille AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 220 employees.

Stille AB develops, manufactures, and distributes medtech products in Sweden, Germany, the United Kingdom, Switzerland, North America, the United States, and internationally. It operates through the Surgical Instruments and Surgical Tables segments. The Surgical Instruments segment offers surgical scissors, including SuperCut, eye, blepharoplasty, operating, vascular, tenotomy, and face-lift scissors; colon, gall duct, multi-purpose, tangential occlusion, peripheral vascular, and anastomosis clamps; skin and nerve hooks, retractors, rib spreaders, self-retaining and trachea retractors, and nasal specula; and dressing, diathermy, knot-holding, tissue, iris, dura, and vascular forceps under th…

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis